Table 1.
Demographic and Clinical Characteristics of Study Participants, by Schistosoma haematobium and Schistosoma mansoni Infection Status
| Characteristic | S. haematobium Status | S. mansoni Status | ||||
|---|---|---|---|---|---|---|
| Infected(n = 18) | Uninfected(n = 39) | P difference | Infected(n = 11) | Uninfected(n = 29) | P difference | |
| Age, y | 21.5 (20–31) | 30 (26–35) | .0043 | 29 (27–35) | 32 (29–38) | .387 |
| Currently breastfeeding | 4 (23.5) | 13 (37.1) | .37 | 2 (18.2) | 7 (24.1) | 1.00 |
| Marital status | ||||||
| Married | 14 (77.8) | 27 (69.2) | .75 | 8 (72.7) | 22 (75.9) | 1.00 |
| Single/widowed/divorced | 4 (22.2) | 12 (30.8) | 3 (27.3) | 7 (24.1) | ||
| Years of school completed | 7 (0–7) | 7 (7–7) | .056 | 7 (5–7) | 7 (2–7) | .754 |
| Ever treated for schistosomiasisa | 3 (16.7) | 5 (12.8) | .70 | 2 (18.2) | 9 (31.0) | .693 |
| HIV positive | 2 (11.1) | 13 (33.3) | .11 | 2 (18.2) | 5 (17.2) | 1.00 |
| S. haematobium ova, no. per 10 mL of urine | 2 (2–12) | 0 (0–0) | <.001 | 0 | 0 | |
| S. mansoni ova, no. per g of stool | 0 | 0 | 48 (4.8–100.8) | 0 (0.0) | <.001 | |
| Serum schistosome CAA level, pg/mL | 218.6 (107.7–1320) | 0 (0–5) | <.001 | 2428 (950–6861) | 2.5 (0–4.7) | <.001 |
Data are no. (%) of participants or median value (interquartile range).
Abbreviations: CAA, circulating anodic antigen; HIV, human immunodeficiency virus.
aIncluding mass drug administration.